Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 808 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 29.57 | NA | 7,875 | 40,065 | 35,361 | ||||||||||||
| 810 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 8.65 | NA | 2,118 | 11,721 | 11,216 | ||||||||||||
| 809 | MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | Non Surgical | 61.78 | NA | 15,133 | 83,718 | 80,784 |
DEMOGRAPHIC DETAILS OF DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 32,742 | 81.72 |
| Black | 4,472 | 11.16 |
| Hispanic | 893 | 2.23 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| 65 to 69 | 8,491 | 21.19 |
| 70 to 74 | 8,333 | 20.8 |
| Less than 65 | 7,471 | 18.65 |
TOP ICD DIAGNOSIS CODES FOR DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 78061 | Fever presenting with conditions classified elsewhere | 9,433 | 23.54 |
| 4019 | Unspecified essential hypertension | 8,526 | 21.28 |
| 28800 | Neutropenia, unspecified | 8,340 | 20.82 |
TOP ICD PROCEDURE CODES FOR DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 9904 | Transfusion Of Packed Cells | 12,783 | 31.91 |
| 30233N1 | Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach | 6,495 | 16.21 |
| 9905 | Transfusion Of Platelets | 5,329 | 13.3 |
TOP HOSPITALS ASSOCIATED WITH DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 1275 YORK AVE | New York | NY | 10065 | 222 | 0.55 |
| University of Texas MD Anderson Cancer Center | 1515 HOLCOMBE BLVD | Houston | TX | 77030 | 171 | 0.43 |
| AdventHealth Orlando | 601 E ROLLINS ST | Orlando | FL | 32803 | 170 | 0.42 |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. SATINDERJIT S OBEROI | 902 N RIVERSIDE RD | SAINT JOSEPH | MO | 64507 | 28 | 0.07 |
| DR. AMANDEEP KAUR DHATT | 200 CARMAN AVE | EAST MEADOW | NY | 11554 | 23 | 0.06 |
| DR. XIUSHENG QIN | 30 HARRISON ST | JOHNSON CITY | NY | 13790 | 21 | 0.05 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Physician Name | Address | City | State | Zip Code | Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| DR. XIUSHENG QIN | 30 HARRISON ST | JOHNSON CITY | NY | 13790 | 17 | 0.04 |
DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 78061 | Fever presenting with conditions classified elsewhere | NA | 9,433 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 4019 | Unspecified essential hypertension | NA | 8,526 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 28800 | Neutropenia, unspecified | NA | 8,340 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 28419 | Other pancytopenia | NA | 7,753 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 486 | Pneumonia, organism unspecified | NA | 7,338 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | R5081 | Fever presenting with conditions classified elsewhere | 8,211 | 7,335 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 2724 | Other and unspecified hyperlipidemia | NA | 6,688 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | I10 | Essential (primary) hypertension | 5,882 | 6,593 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter | 6,413 | 6,512 | |||||||||||||||||
| Oncology & Hematology | Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders | 28411 | Antineoplastic chemotherapy induced pancytopenia | NA | 6,483 |